Skin pigmentation refers to a skin disease in which the skin becomes whiter or darker than the existing skin color. In general, hyperpigmentation disorders are associated with darkening of the skin, and hypopigmentation means lightening of the skin color.
Pigmentation disorders affect the color of the skin, making it look discolored and mottled. Skin color is controlled by a component of the skin called melanin, which is produced by some specialized cells present in the body. Pigmentation is caused by minimal or excessive production of melanin due to damaged or unhealthy melanin-producing cells.
Melanin acts as an absorption filter for UV rays, protecting the skin from sun-induced skin cancer and preventing sunlight from penetrating deep into the skin. The most common pigmentation disorders are melasma (hyperpigmentation disorder), vitiligo (hyperpigmentation), albinism (a rare congenital disorder), and post-inflammatory hyperpigmentation. Melasma is caused by hormonal changes, such as pregnancy and oral contraception. After sun exposure, the concentration of melanin in the skin increases.
Get Free Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17350
Melasma affects between 5 and 6 million women in the United States, accounting for 80% of pregnant women in Mexico and 50% to 75% of pregnant women in the United States. However, vitiligo is an acquired skin disease caused by discoloration or whitening of the skin. Individuals who are overexposed to the sun, hormonal changes, stress, and abuse of cosmetics and hair dyes are at a higher risk of skin pigmentation. Also, heredity and heredity are some of the causes of skin pigmentation.
Treatment of skin pigmentation is very important because people are more interested in improving the appearance of the affected skin. To treat skin pigmentation disorders, a doctor or dermatologist may use topical drugs, pharmacological treatment with hydroquinone, azelaic acid, L-ascorbic acid, and cosmetic treatment with chemical peels, laser therapy, dermabrasion, and skin grafting. We use two approaches. Aesthetic treatment is generally preferred over drug treatment as it provides an effective and efficient solution.
The upgraded lifestyle along with the growing demand for skin whitening is expected to be a major factor driving the pigmentation disorder treatment market. A growing aging population, increasing incidence of skin diseases, increasing smokers, global warming and rising disposable income are some of the other factors fueling the pigmentation disorder treatment market.
Additionally, advances in tissue engineering coupled with the adoption of new technologies and skin care products are expected to further grow the market during the forecast period. However, high costs associated with cosmetic therapies and surgeries are restraining the market growth.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/17350
The global market for the treatment of pigmentation disorders is segmented on the basis of disease indication, treatment type, distributor channel, and geographic region.
| Segmentation by disease indication |
|
| Segmentation by type of treatment |
|
| Segmentation by distribution channel |
|
| Regional segmentation |
|
Because cosmetic treatments can achieve quick and effective results, some types of treatment use cosmetic treatment techniques more widely than others. Also, increasing demand for skin lightening products on the customer side is expected to drive the pigmentation disorder treatment market during the forecast period.
Based on geography, the global pigmentation disorder treatment market is segmented into five major regions. North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America held the largest share of the global pigmentation disorder treatment market and the same trend is expected to continue over the forecast period, owing to an aging population and increasing incidence of skin disorders.
However, the Asia Pacific region is expected to register rapid growth during the forecast period and is expected to be a lucrative market for new market players in the global pigmentation treatment market.
Some of the prominent players present in the global pigmentation disorder treatment market are Episciences, Inc., La Roche-Posay, Bayer AG, Allergan, Inc., SkinCeuticals International, Pierre Fabre Laboratories, Alvogen, Inc., Obagi Medical Products Inc. and others.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/17350
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com